Health
15 Oct 2026
FDA Plans Tailored Framework to Guide Rare Disease Drug Development
The agency aims to replace broad rules with condition-specific standards as it works to reduce uncertainty for biotech developers.
Read moreTopic
#Leerink Partners
1 story